AQST
USDAquestive Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$6.410
Máximo
$6.410
Mínimo
$5.790
Volumen
3.85M
Fundamentos de la Empresa
Capitalización de Mercado
736.9M
Industria
Drug Manufacturers - Specialty & Generic
País
United States
Estadísticas de Negociación
Volumen Promedio
3.10M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Acciones Relacionadas
ZBRA
Zebra Technologies Corporation
CBL
CBL & Associates Properties Inc.
MGRE
Affiliated Managers Group Inc. 6.750% Junior Subordinated Notes due 2064
MEI
Methode Electronics Inc.
EQC
Equity Commonwealth Common Shares of Beneficial Interest
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.